Literature DB >> 1159077

Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".

M C Gershengorn, B D Weintraub.   

Abstract

An 18-yr-old woman with clinical and laboratory features of hyperthyroidism had persistently elevated serum levels of immunoreative thyrotropin (TSH). During 11 yr of follow-up there had been no evidence of a pituitary tumor. After thyrotropin-releasing hormone (TRH), there was a marked increase in TSH and secondarily in triiodothyronine (T3), the latter observation confirming the biologic activity of the TSH. Exogenous T3 raised serum T3 and several measurements of peripheral thyroid hormone effect, while decreasing serum TSH, thyroxine (T4), and thyroidal radioiodine uptake. After T3, the TRH-stimulated TSH response was decreased but was still inappropriate for the elevated serum T3 levels. Dexamethasone reduced serum TSH but did not inhibit TRH stimulation of TSH. Propylthiouracil reduced serum T4 and T3 and raised TSH. This patient represents a new syndrome of TSH-induced hyperthyroidism, differing from previous reports in the absence of an obvious pituitary tumor and in the responsiveness of the TSH to TRH stimulation and thyroid hormone suppression. This syndrome appears to be caused by a selective, partial resistance of the pituitary to the action of thyroid hormone. This case is also compared with previous reports in the literature of patients with elevated serum levels of immunoreactive TSH in the presence of elevated total and free thyroid hormones. A classification of these cases, termed "inappropriate secretion of TSH," is proposed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159077      PMCID: PMC301911          DOI: 10.1172/JCI108133

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Standards for the basal metabolism of normal people in Britain.

Authors:  J D ROBERTSON; D D REID
Journal:  Lancet       Date:  1952-05-10       Impact factor: 79.321

2.  Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone.

Authors:  S Refetoff; L T DeWind; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

3.  Thyrotropic tumor syndrome. A multiglandular disease induced by sustained deficiency of thyroid hormones.

Authors:  J Furth; P Moy; J M Hershman; G Ueda
Journal:  Arch Pathol       Date:  1973-10

4.  Congenital euthyroid goitre and partial peripheral resistance to thyroid hormones.

Authors:  B A Lamberg
Journal:  Lancet       Date:  1973-04-21       Impact factor: 79.321

5.  Hyperthyroidism and excessive thyrotropin secretion.

Authors:  C H Emerson; R D Utiger
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

6.  Thyrotrophin-releasing hormone as a thyroid-function test.

Authors:  B J Ormston; R J Cryer; R Garry; G M Besser; R Hall
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

7.  Determination of thyroid volume by ultrasonic scanning.

Authors:  S N Rasmussen; L Hjorth
Journal:  J Clin Ultrasound       Date:  1974-06       Impact factor: 0.910

8.  Utility of the radioimmunoassay of serum thyrotrophin in man.

Authors:  J M Hershman; J A Pittman
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

9.  Growth hormone in thyrotoxicosis: effect of insulin-induced hypoglycemia.

Authors:  J A Burgess; B R Smith; T J Merimee
Journal:  J Clin Endocrinol Metab       Date:  1966-11       Impact factor: 5.958

10.  Alterations in thyroid hormone economy in patients with hydatidiform mole.

Authors:  V A Galton; S H Inggar; J Jimenez-Fonseca; J M Hershman
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

View more
  34 in total

1.  History of the clinical endocrinology branch of the National Institute of Diabetes and Digestive and Kidney Diseases: impact on understanding and treatment of diseases of the thyroid gland.

Authors:  Marvin C Gershengorn
Journal:  Thyroid       Date:  2012-01-18       Impact factor: 6.568

Review 2.  Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options.

Authors:  Satoru Suzuki; Satoshi Shigematsu; Hidefumi Inaba; Masahiro Takei; Teiji Takeda; Mitsuhisa Komatsu
Journal:  Endocrine       Date:  2011-09-29       Impact factor: 3.633

3.  Tight linkage of the human c-erbA beta gene with the syndrome of generalized thyroid hormone resistance is present in multiple kindreds.

Authors:  H G Fein; K D Burman; Y Y Djuh; S J Usala; A E Bale; B D Weintraub; R C Smallridge
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

4.  Another story of mice and men: the types of RTH.

Authors:  Paul Webb
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-03       Impact factor: 11.205

5.  Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol.

Authors:  M Aguilar Diosdado; L Escobar-Jimenez; M L Fernandez Soto; A Garcia Curiel; F Escobar-Jimenez
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

6.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

7.  Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.

Authors:  I M Spitz; M Sheinfeld; B Glasser; H J Hirsch
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

8.  Transient infantile hyperthyrotropinaemia. Report of a case.

Authors:  K Miyai; N Amino; K Nishi; T Fujie; K Nakatani; O Nose; T Harada; H Yabuuchi; K Doi; T Yamamoto; R Satake; T Tsuruhara; T Oura
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

9.  Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC).

Authors:  P Beck-Peccoz; G Piscitelli; M G Cattaneo; G Faglia
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

10.  Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome.

Authors:  M C Gershengorn; C O Arevalo; E Geras; M J Rebecchi
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.